Test Directory
| Test Code | |||||
| GOLGA | |||||
| Test Name | |||||
| Golimumab and Anti-Gol Ab | |||||
| CPT Codes | |||||
| 80299, 82397 | |||||
| Included Tests | |||||
|
|||||
| Expected Turnaround Time | |||||
| 7 - 18 days | |||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum
Preferred Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain
Desired Specimen Volume: 3 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Patient Preparation | |||||
|
High serum biotin concentrations in patients taking biotin supplements may cause an interference in this assay. Patients may be advised to stop biotin consumption at least 72 hours prior to sample collection. |
|||||
| Transport Instructions | |||||
|
Transport to the laboratory frozen. |
|||||
| Stability Requirements | |||||
|
|||||
| Causes for Rejection | |||||
|
|||||
| Methodology | |||||
| Electrochemiluminescence Immunoassay | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Failure of golimumab therapy may not always be due to the presence of anti-golimumab antibodies. Conversely, the absence of anti-golimumab antibodies does not guarantee response to treatment. |
|||||
| Alternate Names | |||||
|
|||||
| Reference Lab | |||||
| Mayo Clinic Laboratories | |||||
| Testing Schedule | |||||
| Routine, 1 time per week | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.